These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12598077)

  • 1. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease.
    Probst V; Kyndt F; Potet F; Trochu JN; Mialet G; Demolombe S; Schott JJ; Baró I; Escande D; Le Marec H
    J Am Coll Cardiol; 2003 Feb; 41(4):643-52. PubMed ID: 12598077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
    Probst V; Allouis M; Sacher F; Pattier S; Babuty D; Mabo P; Mansourati J; Victor J; Nguyen JM; Schott JJ; Boisseau P; Escande D; Le Marec H
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):270-5. PubMed ID: 16643399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.
    Vanninen SUM; Nikus K; Aalto-Setälä K
    Ann Med; 2017 Sep; 49(6):496-503. PubMed ID: 28294644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
    Hu D; Barajas-Martinez H; Nesterenko VV; Pfeiffer R; Guerchicoff A; Cordeiro JM; Curtis AB; Pollevick GD; Wu Y; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):274-85. PubMed ID: 20025708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an overlap syndrome really exist between Brugada syndrome and progressive cardiac conduction defect (Lenegre syndrome)?
    Shimizu W
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):276-8. PubMed ID: 16643400
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis.
    Royer A; van Veen TA; Le Bouter S; Marionneau C; Griol-Charhbili V; Léoni AL; Steenman M; van Rijen HV; Demolombe S; Goddard CA; Richer C; Escoubet B; Jarry-Guichard T; Colledge WH; Gros D; de Bakker JM; Grace AA; Escande D; Charpentier F
    Circulation; 2005 Apr; 111(14):1738-46. PubMed ID: 15809371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
    Smits JP; Eckardt L; Probst V; Bezzina CR; Schott JJ; Remme CA; Haverkamp W; Breithardt G; Escande D; Schulze-Bahr E; LeMarec H; Wilde AA
    J Am Coll Cardiol; 2002 Jul; 40(2):350-6. PubMed ID: 12106943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect.
    Niu DM; Hwang B; Hwang HW; Wang NH; Wu JY; Lee PC; Chien JC; Shieh RC; Chen YT
    J Med Genet; 2006 Oct; 43(10):817-21. PubMed ID: 16707561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias.
    Laitinen-Forsblom PJ; Mäkynen P; Mäkynen H; Yli-Mäyry S; Virtanen V; Kontula K; Aalto-Setälä K
    J Cardiovasc Electrophysiol; 2006 May; 17(5):480-5. PubMed ID: 16684018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.
    Bezzina CR; Rook MB; Groenewegen WA; Herfst LJ; van der Wal AC; Lam J; Jongsma HJ; Wilde AA; Mannens MM
    Circ Res; 2003 Feb; 92(2):159-68. PubMed ID: 12574143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block.
    Wang DW; Viswanathan PC; Balser JR; George AL; Benson DW
    Circulation; 2002 Jan; 105(3):341-6. PubMed ID: 11804990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction.
    Bezzina CR; Shimizu W; Yang P; Koopmann TT; Tanck MW; Miyamoto Y; Kamakura S; Roden DM; Wilde AA
    Circulation; 2006 Jan; 113(3):338-44. PubMed ID: 16415376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.
    McNair WP; Sinagra G; Taylor MR; Di Lenarda A; Ferguson DA; Salcedo EE; Slavov D; Zhu X; Caldwell JH; Mestroni L;
    J Am Coll Cardiol; 2011 May; 57(21):2160-8. PubMed ID: 21596231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging.
    Hao X; Zhang Y; Zhang X; Nirmalan M; Davies L; Konstantinou D; Yin F; Dobrzynski H; Wang X; Grace A; Zhang H; Boyett M; Huang CL; Lei M
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):397-406. PubMed ID: 21493874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed conduction and its implications in murine Scn5a(+/-) hearts: independent and interacting effects of genotype, age, and sex.
    Jeevaratnam K; Poh Tee S; Zhang Y; Rewbury R; Guzadhur L; Duehmke R; Grace AA; Lei M; Huang CL
    Pflugers Arch; 2011 Jan; 461(1):29-44. PubMed ID: 21127902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.